IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 104 filers reported holding IVERIC BIO INC in Q3 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,265,000 | -39.6% | 517,445 | -40.9% | 1.71% | -41.6% |
| Q1 2021 | $5,409,000 | -2.2% | 875,180 | +9.4% | 2.92% | -31.0% |
| Q4 2020 | $5,528,000 | -58.5% | 800,000 | -66.1% | 4.23% | -69.5% |
| Q3 2020 | $13,323,000 | -4.6% | 2,362,240 | -13.8% | 13.86% | -48.8% |
| Q2 2020 | $13,972,000 | +57.2% | 2,739,641 | +6.0% | 27.06% | +187.9% |
| Q1 2020 | $8,888,000 | -65.5% | 2,583,786 | -13.9% | 9.40% | -47.6% |
| Q4 2019 | $25,740,000 | +500.7% | 3,000,000 | -21.6% | 17.94% | +331.4% |
| Q3 2019 | $4,285,000 | -19.9% | 3,825,903 | -7.0% | 4.16% | +13.0% |
| Q2 2019 | $5,348,000 | – | 4,113,522 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |